Top compounds associated with response to IGFL1


Feature Type Standardized
Nominal ANOVA
mRNA tosedostat CTRPv2 pan-cancer AAC 0.045 0.2
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.039 0.2
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.042 0.2
mRNA MG-132 GDSC1000 pan-cancer AAC -0.067 0.2
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.067 0.2
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.078 0.2
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.044 0.2
Download CSV